Products for Research Use Only
RegisterLogin

Saralasin (TFA)

CAT: 0804-HY-P0205B-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P0205B-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Saralasin ([Sar1, Ala8] Angiotensin II) TFA is an octapeptide analog of angiotensin II. Saralasin TFA is a competitive angiotensin II receptor antagonist with a Ki value of 0.32 nM for 74% of the binding sites, and has partial agonist activity as well. Saralasin TFA can be used for the research of renovascular hypertension, renin-dependent (angiotensinogenic) hypertension[1][3][6].
Product Name Alternative
[Sar1, Ala8] Angiotensin II (TFA)
UNSPSC
12352209
Target
Angiotensin Receptor
Type
Peptides
Related Pathways
GPCR/G Protein
Field of Research
Inflammation/Immunology; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/saralasin-tfa.html
Purity
99.18
Solubility
DMSO : 50 mg/mL (ultrasonic) |H2O : 100 mg/mL (ultrasonic)
Smiles
C[C@H](NC([C@H]1N(CCC1)C([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(CNC)=O)CCCNC(N)=N)=O)C(C)C)=O)CC2=CC=C(O)C=C2)=O)C(C)C)=O)CC3=CNC=N3)=O)=O)C(O)=O.OC(C(F)(F)F)=O
Molecular Formula
C44H66F3N13O12
Molecular Weight
1026.07
References & Citations
[1]P Schelling, et al. Effects of angiotensin II and angiotensin II antagonist saralasin on cell growth and renin in 3T3 and SV3T3 cells. J Cell Physiol. 1979 Mar;98 (3) :503-13. |[2]Jeremy H Kim, et al. Pressure-overload-induced angiotensin-mediated early remodeling in mouse heart. PLoS One. 2017 May 2;12 (5) :e0176713. |[3]Maziar Mohammad Akhavan, et al. A non-radioactive method for angiotensin II receptor binding studies using the rat liver. J Pharmacol Toxicol Methods. 2006 May-Jun;53 (3) :206-14. |[4]M Mikuni, et al. Saralasin-induced inhibition of ovulation in the in vitro perfused rat ovary is not replicated by the angiotensin II type-2 receptor antagonist PD123319. Am J Obstet Gynecol. 1998 Jul;179 (1) :35-40. |[5]Siu Po Ip, et al. Saralasin, a nonspecific angiotensin II receptor antagonist, attenuates oxidative stress and tissue injury in cerulein-induced acute pancreatitis. Pancreas. 2003 Apr;26 (3) :224-9. |[6]Campbell WB, et al. Saralasin-induced renin release: its blockade by prostaglandin synthesis inhibitors in the conscious rat. Hypertension. 1979;1 (6) :637‐642.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
Launched

Related Products

CatalogName
HY-P0205-01Saralasin
HY-P2438Thr8-saralasin
HY-P0205ASaralasin (acetate hydrate)
HY-P5380ATNO211 (TFA)
HY-P4668A-01Valylleucine (TFA)
HY-P11296A-01LLVK (TFA)
HY-P10927A-01BRP (TFA)
HY-P10333A-01LIH383 (TFA)
HY-P3970D-01KQFK (TFA)
HY-P3460A-01TDSRCVIGLYHPPLQVY (TFA)

Alternative Products

CatalogName
MBS5817642Saralasin TFA
TRC-S142630-10MGSaralasin TFA Salt
GTR19029307Saralasin
C06887-5mgSaralasin Acetate
T26274Thr8-saralasin
256606Saralasin discontinued
A2294-50PAngiotensin II [Sar1, Val5, Ala8] (Saralasin)
GTR19155198-01Saralasin acetate (34273-10-4 free base)
MBS3613986-01Saralasin acetate(34273-10-4 free base)

Popular Products